MindMed Files 8-K: Other Events & Financials

Ticker: DFTX · Form: 8-K · Filed: Sep 4, 2025 · CIK: 1813814

Mind Medicine (Mindmed) Inc. 8-K Filing Summary
FieldDetail
CompanyMind Medicine (Mindmed) Inc. (DFTX)
Form Type8-K
Filed DateSep 4, 2025
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: 8-K, financial-reporting, regulatory-filing

Related Tickers: MNMD

TL;DR

MindMed filed an 8-K on Sept 4, 2025, covering other events and financials. Details pending.

AI Summary

On September 4, 2025, Mind Medicine (MindMed) Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and operational events. No specific financial figures or new material events were detailed in the provided excerpt.

Why It Matters

This 8-K filing signals that Mind Medicine (MindMed) Inc. is providing updates to the SEC, which could include important operational or financial information relevant to investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for 'Other Events' and 'Financial Statements and Exhibits' without immediate disclosure of significant negative events.

Key Players & Entities

  • Mind Medicine (MindMed) Inc. (company) — Registrant
  • September 04, 2025 (date) — Date of earliest event reported

FAQ

What specific 'Other Events' are being reported by Mind Medicine (MindMed) Inc. in this 8-K filing?

The provided excerpt does not detail the specific 'Other Events' being reported; it only lists the item category.

What is the significance of the 'Financial Statements and Exhibits' being filed?

This indicates that Mind Medicine (MindMed) Inc. is providing updated financial information or exhibits as required by the SEC, though the specifics are not in this excerpt.

What is the exact date of the earliest event reported in this 8-K?

The exact date of the earliest event reported is September 04, 2025.

What is the Commission File Number for Mind Medicine (MindMed) Inc.?

The Commission File Number for Mind Medicine (MindMed) Inc. is 001-40360.

Where is Mind Medicine (MindMed) Inc.'s principal executive office located?

Mind Medicine (MindMed) Inc.'s principal executive office is located at One World Trade Center, Suite 8500, New York, New York, 10007.

Filing Stats: 444 words · 2 min read · ~1 pages · Grade level 11.7 · Accepted 2025-09-04 11:15:28

Filing Documents

01 Other Events

Item 8.01 Other Events. On September 4, 2025, Mind Medicine (MindMed), Inc. (the "Company") issued a press release (the "Press Release") announcing the publication of the results from the Company's Phase 2b clinical trial of MM120 (Lysergide D-Tartrate) in Generalized Anxiety Disorder in the Journal of the American Medical Association. A copy of the Press Release is attached as Exhibit 99.1 hereto, and is incorporated by reference herein.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release, dated September 4, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIND MEDICINE (MINDMED) INC. Date: September 4, 2025 By: /s/ Robert Barrow Name: Robert Barrow Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.